miR‐185‐3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT 2B in vitro

Author:

Li Guo12,Wang Yunyun12,Liu Yong12,Su Zhongwu12,Liu Chao12,Ren Shuling12,Deng Tengbo12,Huang Donghai12,Tian Yongquan12,Qiu Yuanzheng12

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery Xiangya Hospital Central South University ChangshaChina

2. Otolaryngology Major Disease Research Key Laboratory of Hunan Province Changsha Hunan China

Funder

National Natural Science Foundation of China

Research Fund for the Doctoral Program of Higher Education of China

the Freedom Explore Program of Central South University

the Graduate Student Research Innovation Project of Hunan Province

the Open-End Fund for the Valuable and Precision Instruments of Central South University

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference43 articles.

1. Nasopharyngeal carcinoma

2. Recent advances in the treatment of nasopharyngeal carcinoma;Chang JT;J Formos Med Assoc,2004

3. Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma;Mostafa E;J Egypt Natl Canc Inst,2006

4. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction;Gupta AK;Clin Cancer Res,2002

5. Biological Basis of miRNA Action when Their Targets Are Located in Human Protein Coding Region

Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3